Clinical Trials Are Pivotal in the Evolution of CAR-T Cell Therapy in Multiple Myeloma
August 18th 2020While the use of CAR-T cell therapy is currently still being investigated in patients with multiple myeloma, Dr. Nina Shah of the UCSF Helen Diller Family Comprehensive Cancer Center believes that these clinical trials will be what ultimately moves the field forward.
Watch